Article ID Journal Published Year Pages File Type
4212276 Respiratory Medicine 2006 10 Pages PDF
Abstract

SummaryPurposeTo compare the effects on exercise capacity and health related quality of life (HRQoL) of two exercise programmes; one programme including endurance training and one including only resistance training and callisthenics. A second purpose was to find out whether the severity of chronic obstructive pulmonary disease (COPD) affected the training response and whether the interventions had a long-term effect.MethodsSixty-three patients were stratified according to severity of COPD and randomised to two training groups. Group A had a mixed programme including endurance training. Group B had resistance training and callisthenics. All trained twice weekly for 8 weeks. A symptom-limited ergometer test, 12-min walking test, dynamic spirometry, blood gas analysis at rest and HRQoL were measured before and after the training period. Follow-up tests were conducted at 6 and 12 months after training.ResultsForty-two patients fulfilled the trial. In group A (n=20n=20) peak exercise capacity increased by 7 W (P<0.001P<0.001) and 12-min walking distance (12MWD) by 50 m (P<0.01P<0.01), whereas group B (n=22n=22) did not change in any of these variables. HRQoL did not change significantly in either group. Training response was similar in patients with moderate and severe disease. One year post-training 12MWD had returned to pre-training level in group A, and below pre-training level in group B (P<0.05P<0.05).ConclusionsExercise capacity in patients with severe and moderate COPD improved by intensive endurance training, two sessions a week for 8 weeks. The improvement was however small and HRQoL did not improve. Severity of illness did not affect response to training. The results indicated that the effects of a short endurance training intervention slowed down decline in baseline functional exercise capacity for 1 year.

Related Topics
Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine
Authors
, , , ,